Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shea

Showing results (631-640 of 672) with videos related to

Pageof 68
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast CancerXian Wang, Jamunarani Veeraraghavan, Chia-Chia Liu, et al.
Research Synthesis Methods|December 20, 2021
A new taxonomy was developed for overlap across 'overviews of systematic reviews': A meta-research study of research wasteCarole Lunny, Emma K Reid, Trish Neelakant, et al.
Cell Research|May 31, 2014
An epigenomic approach to therapy for tamoxifen-resistant breast cancerQin Feng, Zheng Zhang, Martin J Shea, et al.
British Journal of Cancer|December 18, 2018
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistanceAgostina Nardone, Hazel Weir, Oona Delpuech, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working GroupSabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, et al.
The Journal of Rheumatology|February 17, 2019
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention StudiesMaarten Boers, Dorcas E Beaton, Beverley J Shea, et al.
Thorax|January 29, 2017
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA studyAnna J Podolanczuk, Ganesh Raghu, Michael Y Tsai, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
Seminars in Arthritis and Rheumatism|January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological studyYing-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Psychoneuroendocrinology|October 24, 2025
Psychobiological reactivity to acute psychological stress as a predictor of cardiovascular disease and mortality: The Multi-Ethnic Study of AtherosclerosisAiden J Chauntry, Justin B Moore, Teresa Seeman, et al.
Pageof 68

Showing results (631-640 of 672) with videos related to

Sort By:
Pageof 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast CancerXian Wang, Jamunarani Veeraraghavan, Chia-Chia Liu, et al.
Research Synthesis Methods|December 20, 2021
A new taxonomy was developed for overlap across 'overviews of systematic reviews': A meta-research study of research wasteCarole Lunny, Emma K Reid, Trish Neelakant, et al.
Cell Research|May 31, 2014
An epigenomic approach to therapy for tamoxifen-resistant breast cancerQin Feng, Zheng Zhang, Martin J Shea, et al.
British Journal of Cancer|December 18, 2018
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistanceAgostina Nardone, Hazel Weir, Oona Delpuech, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working GroupSabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, et al.
The Journal of Rheumatology|February 17, 2019
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention StudiesMaarten Boers, Dorcas E Beaton, Beverley J Shea, et al.
Thorax|January 29, 2017
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA studyAnna J Podolanczuk, Ganesh Raghu, Michael Y Tsai, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
Seminars in Arthritis and Rheumatism|January 6, 2026
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological studyYing-Ying Leung, Tobias Haugegaard, Tommy Kok Annfeldt, et al.
Psychoneuroendocrinology|October 24, 2025
Psychobiological reactivity to acute psychological stress as a predictor of cardiovascular disease and mortality: The Multi-Ethnic Study of AtherosclerosisAiden J Chauntry, Justin B Moore, Teresa Seeman, et al.
Pageof 68